3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
6
Sarcoma
5
Other hematologic neoplasm
5
Myeloid
4
Dermatologic
4
Plasma cell
3
CNS
3
Other neoplasm
2
Genitourinary
2
Other solid neoplasm
1
Head & Neck
1
Gastrointestinal
1
Classical hematology
1
Breast
1
Conditions
Carcinoma, Hepatocellular
10
Pancreatic Neoplasms
9
Neoplasm Metastasis
5
Breast Neoplasms
5
Melanoma
4
Colorectal Neoplasms
4
Prostatic Neoplasms
3
Ovarian Neoplasms
3
Lymphoma
3
Lung Neoplasms
3
Liver Neoplasms
3
Carcinoma, Renal Cell
3
Wilms Tumor
2
Urinary Bladder Neoplasms
2
Stomach Neoplasms
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Neuroblastoma
2
Neoplasms, Germ Cell and Embryonal
2
Neoplasms
2
Kidney Neoplasms
2
Astrocytoma
2
Adenomatous Polyposis Coli
2
Thyroid Neoplasms
1
Thrombocytosis
1
Somatostatinoma
1
Sarcoma, Clear Cell
1
Retinoblastoma
1
Interventions
Oxaliplatin
10
Gemcitabine
8
Cisplatin
7
Hepatectomy
6
Fluorouracil
6
Radiofrequency Ablation
5
Liver Transplantation
5
Irinotecan
5
Capecitabine
5
lenvatinib
4
Paclitaxel
4
Neoadjuvant Therapy
4
Folfox protocol
4
Cetuximab
4
Aspirin
4
tislelizumab
3
Surgical Procedures, Operative
3
Nivolumab
3
Carboplatin
3
titanium silicide
2
durvalumab
2
apatinib
2
Trastuzumab
2
S 1 (combination)
2
Leucovorin
2
Lamivudine
2
Introns
2
Ethiodized Oil
2
Drug Therapy
2
DNA, Mitochondrial
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recurrence
×
Sirolimus
×
Gastrointestinal
×
Clear all
NCT01331135
2020-05-29
Aflac ST0901
Emory University
Phase 1
Completed
18 enrolled